论文信息 - Artificial intelligence for cancer-associated thrombosis risk assessment. - 字舞流文

Artificial intelligence for cancer-associated thrombosis risk assessment.

Fabio Massimo Zanzotto | Fiorella Guadagni | Patrizia Ferroni | Mario Roselli | F. Guadagni | P. Ferroni | M. Roselli | Fabio M Zanzotto

[1] P. Wu,et al. Advanced Big Data Analytics for -Omic Data and Electronic Health Records: Toward Precision Medicine. , 2016, IEEE transactions on bio-medical engineering.

[2] P. Wells,et al. Implementation and validation of a risk stratification method at The Ottawa Hospital to guide thromboprophylaxis in ambulatory cancer patients at intermediate-high risk for venous thrombosis. , 2015, Thrombosis research.

[3] A. Khorana. Simplicity versus complexity: an existential dilemma as risk tools evolve. , 2018, The Lancet. Haematology.

[4] Fabio Massimo Zanzotto,et al. Validation of a Machine Learning Approach for Venous Thromboembolism Risk Prediction in Oncology , 2017, Disease markers.

[5] Georg Heinze,et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. , 2018, The Lancet. Haematology.